Coming full circle on IVF

One useful lens here is that IVF is not just a clinical procedure; it is also a health-system service shaped by law, insurance, and geography. That means access can change quickly even when the underlying biology of fertility has not. For readers, the key question is not only whether IVF works, but who can reach it in time, and under what constraints.

The article also highlights a common evidence trap: legal or market decisions can be mistaken for medical necessity. Restrictions may be justified as protecting embryos, but the downstream effect is to limit treatment options for people with infertility. That does not prove one policy causes better or worse health outcomes; it does show that policy can alter whether care is available at all.

Another practical issue is uneven availability. When clinics cluster where patients can pay, access becomes tied to income, employer benefits, and local regulation. That creates a real-world trade-off between innovation and equity: a treatment can be technically established and still remain out of reach for many families.

For health readers, the broader lesson is about fragility in reproductive care. IVF depends on laboratory infrastructure, specialist staff, and predictable rules. When any of those shift, the impact is felt long before statistics catch up. The uncertainty here is not whether infertility is real, but how much access to treatment will depend on politics rather than medical need.


A return to an old anti-IVF playbook When an Alabama university decided it wouldย pause IVF treatmentsย after theย stateโ€™s Supreme Courtย said thatย frozen embryos should be considered children, it was not the first time abortion politics interfered with access to fertility treatment.You see, a key tenet in the anti-abortion argument is that life begins when an egg and sperm meet. Those in favor of abortion access argue it starts later, when the fetus becomes viable. Thisย point of ideological contentionย is whyย state lawsย range from banning abortion atย six weeks after fertilization to allowing it up to 24 weeks of gestation (or, of course, outright banning it or having no cutoff at all). When theย Alabama Supreme Court ruledย those who destroy frozen embryos are liable for wrongful death, they essentially fell back on an age-old anti-abortion argument:ย that a cluster of cells is a person as soon as sperm fertilizes anย egg.ย That meansย doctors who perform IVF procedures could end up being criminally prosecuted if, say, they disposed of embryos that arenโ€™t viable โ€” those that have no chance of ever developing into a healthy person, or perhaps not even developing once implanted at all. Theย threat has the potential to shut down clinics that donโ€™t want to face what could end up being a legal nightmare. โ€œThis really does mean that IVF is likely to become completely inaccessible in the state,โ€ย Katie Oโ€™Connor, director of federal abortion policy at the National Womenโ€™s Law Center,ย told my colleagues.ย Abortion politics have been intertwined with fertility treatment in the US since before theย very first IVF babyย was born in the UK in 1978. In a sense, IVF and the anti-abortion movement grew up together. In the 1970s, as scientists around the world were racing to figure out how to make a viable embryo in a Petri dish, the Roe v. Wade decision had just kicked the anti-abortion movement into high gear. Anti-abortion activists argued that life began when sperm and eggs combined. It didnโ€™t matter whether that conception was in a person or a Petri dish.ย This turned IVF research into a lightning rod, as Rutgers University historianย Margaret Marsh and herย sister Wanda Ronner, a gynecologist, chronicle in their bookย The Pursuit of Parenthood.โ€œIn 1979, a year after the birth of the worldโ€™s first IVF baby, a coalition of anti-abortion organizations denounced IVF in an ad in the New York Times as a โ€˜morally abhorrentโ€™ technology, and they successfully thwarted all efforts to allow federal funding for any research using human embryos,โ€ย Marsh told me via email. Fear of political blowback interfered with the US weighing in on IVF.ย When a federalย ethics advisory board eventually issuedย support for it,ย  someย 13,000ย people sent in public comment, most of them in opposition. Aย moratorium on funding research involving embryos remained in effect. And federal funding typically fuels new basic research. That meant that even as scientists in countries like Australiaย and the UK were making breakthroughs that would eventually help people suffering from infertility start families, in the USย the leading scientists who wanted to do IVF research werenโ€™t pursuing it.ย Whenย it became clear that IVF was too lucrative and important for US clinics not to even try, private funding stepped in to bring it to America.ย  The first US IVF babyย was born in 1981ย at the teeny, little-known Eastern Virginia Medical School. Anti-abortion activists protested the clinic. But, asย Marsh explained it to me, the schoolย was just five years old, so it didn’t have an established reputation to lose or an existing stream of federal research dollars at risk. The market opportunity for IVF was โ€” and is โ€” huge. Today,ย one in sixย people are impacted by infertility, according to the World Health Organization. And eventually the market won out over the politics. The number of assisted reproductive technology procedures โ€” includingย IVF โ€” was 413,776 in 2021, up 78% from 2015, according to theย Centers for Disease Control and Prevention.ย The global fertility market is expected to balloon to $84 billionย by 2028, according to market research firm Imarc. โ€œOver the years, the anti-abortion movement gradually accepted some reproductive technologies, as long as no embryos were destroyed during their use,โ€ Marsh told me. โ€œBut the peace it made with the new technologies was always an uneasy peace.โ€Thatย early dissent from anti-abortion activistsย had a lasting impact on the way the industry took shape โ€” it is part of why, for so many people,ย IVF is difficult to access.ย Several early Congressional attempts to regulate the IVF industry failed, leaving clinicsย to come up with protocols and procedures on their own. Without any sort of official endorsement for fertility treatment, few states enacted mandates to cover it and insurers in those states felt no pressure to cover the expensive procedure.ย Still today,ย most statesย do not require private insurers to offer fertility benefits. Onlyย 43% of large US employersย offered IVF coverage in 2022.ย IVF is impossible for most people to afford, typically costing upwards of $10,000 per cycle.ย So market forces mean clinics are largely clustered in wealthier regions where there are more patients who can pay for it. Now political forces stand to put IVF even further out of reach.ย โ€”ย Kristen V. Brown

Enjoyed this article? Sign up for our newsletter to receive regular insights and stay connected.